World Journal of Hepatology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 5259403

Number of visits today: 14417

Number of downloads: 3388982

PUBLISHING PARTNER

INDEXING/ABSTRACTING

MEMBERSHIP

BPG JOURNALS

Open-Access Journal

Other Issues: Previous | Next | Latest | Archive | Download full issue 3 (717)

Contents Volume 2 Issue 3 March 27, 2010

Editorial

Effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis B

Konstantinos Tziomalos

World J Hepatol 2(3):91-93. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.91

Abstract (959) | Core Tip (628) | Full Article (HTML) (2051) | Full Article (PDF)-515K (245) | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (6) | Total Visits (4020) | Similar Articles (1864) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Guidelines For Basic Science

Interactions of chemical carcinogens and genetic variation in hepatocellular carcinoma

Yu-Jing Zhang

World J Hepatol 2(3):94-102. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.94

Abstract (968) | Core Tip (673) | Full Article (HTML) (3369) | Full Article (PDF)-707K (266) | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (27) | Total Visits (5419) | Similar Articles (1699) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Guidelines For Clinical Practice

Medical treatment of unresectable hepatocellular carcinoma: Going beyond sorafenib

Camillo Porta, Chiara Paglino

World J Hepatol 2(3):103-113. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.103

Abstract (960) | Core Tip (649) | Full Article (HTML) (2558) | Figures (1-2) (276) | Tables (1-3) (258) | Full Article (PDF)-857K (282) | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (11) | Total Visits (5176) | Similar Articles (1699) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Review

Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma

Caecilia HC Sukowati, Natalia Rosso, Lory S Crocè, Claudio Tiribelli

World J Hepatol 2(3):114-126. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.114

Abstract (1053) | Core Tip (634) | Full Article (HTML) (6036) | Figures (1-3) (288) | Tables (1-2) (327) | Full Article (PDF)-880K (522) | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (37) | Total Visits (9048) | Similar Articles (1769) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Brief Article

Proteomic analysis for developing new biomarkers of hepatocellular carcinoma

Maria Pleguezuelo, Laura M Lopez-Sanchez, Antonio Rodriguez-Ariza, Jose L Montero, Javier Briceno, Ruben Ciria, Jordi Muntane, Manuel de la Mata

World J Hepatol 2(3):127-135. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.127

Abstract (1057) | Core Tip (636) | Full Article (HTML) (3994) | Figures (1-4) (236) | Tables (1-2) (272) | Full Article (PDF)-862K (495) | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (11) | Total Visits (6850) | Similar Articles (0) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Case Report

Granulocyte colony-stimulating factor as a novel adjunct to improve hepatitis B vaccination

Sudeep Tanwar, Mark Thursz

World J Hepatol 2(3):136-138. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.136

Abstract (1224) | Core Tip (673) | Full Article (HTML) (2233) | Full Article (PDF)-510K (225) | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (2) | Total Visits (4497) | Similar Articles (223) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Write to the Help Desk

© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345